Cognizant Gets a Buy Rating from BMO Capital
- Kelley Robertson
WFG Advisors LP now owns 1,958 shares of the information technology service provider's stock worth $130,000 after buying an additional 621 shares in the last quarter. Cognizant Technology Solutio now has $41.58B valuation. The stock decreased 1.46% or $1.04 during the last trading session, reaching $70.32. During the most recent session, shares touched $70.98 after moving 1.17%. It has underperformed by 11.20% the S&P500. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has "Neutral" rating given on Friday, September 9 by Wedbush. BioScrip had 12 analyst reports since August 11, 2015 according to SRatingsIntel. The firm has "Buy" rating by RBC Capital Markets given on Thursday, August 3. Dougherty & Company maintained BioScrip, Inc. (NASDAQ:NTAP), 14 have Buy rating, 8 Sell and 22 Hold. The stock of BioScrip, Inc.
The company also recently announced a quarterly dividend, which was paid on Thursday, November 30th. Credit Suisse maintained the stock with "Buy" rating in Thursday, November 2 report.
Cognizant has an analyst consensus of Strong Buy, with a price target consensus of $85.43. The company was downgraded on Tuesday, October 11 by FBR Capital. Fdx Advsr reported 13,518 shares stake. 66,965 are owned by Grandfield & Dodd Ltd Co. E Trade Financial Corp (NASDAQ:ETFC) was reduced too. Cognizant Technology Solutions Corporation (NasdaqGS:CTSH) presently has a 10 month price index of 1.38665. Therefore 77% are positive. Also, CEO Francisco Dsouza sold 482,000 shares of the company's stock in a transaction on Tuesday, November 21st. As per Wednesday, November 1, the company rating was maintained by Cowen & Co. The firm has "Positive" rating by Susquehanna given on Wednesday, September 21. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) earned "Hold" rating by Loop Capital on Tuesday, January 10. The ERP5 of Cognizant Technology Solutions Corporation (NasdaqGS:CTSH) is 3315.
A number of analysts recently commented on the stock. As per Friday, September 30, the company rating was downgraded by Citigroup. Its down 0.15, from 0.91 in 2017Q1.
Strategic investors have taken a closer look of late at shares of Cognizant Technology Solutions Corporation (NASDAQ:CTSH). 19 funds opened positions while 41 raised stakes. 716,500 are held by Sentry Investments Corporation. Brandes Investment Prtn Limited Partnership stated it has 258,052 shares. Oakworth Cap holds 28 shares or 0% of its portfolio.
Injustice 2: The Atom's Gameplay Trailer Proves Size Matters
He also has a throw which sees him fly into his opponent's head, forcing them to smack themselves in order to dislodge Atom. Choi also has a stun gun that can be used for combos and numerous concoctions to freeze the player or just do some damage.
361 Capital LLC purchased a new stake in shares of Cognizant Technology Solutions Corp (NASDAQ:CTSH) during the 3rd quarter, according to its most recent filing with the SEC. Exxonmobil Incorporated Tx accumulated 113,087 shares or 0.19% of the stock. Pzena Investment Management LLC now owns 7,010,880 shares of the information technology service provider's stock worth $465,522,000 after purchasing an additional 296,899 shares in the last quarter. Amica Mutual Insurance Company has invested 0.57% of its portfolio in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Cooke Bieler Lp holds 0.13% or 105,280 shares. Bancshares Of New York Mellon Corporation reported 0% stake. "Decreases Position in Cognizant Technology Solutions Corp (NASDAQ:CTSH)" was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. Md Sass Investors Svcs owns 747,623 shares or 3.25% of their U.S. portfolio. The Gross Margin Score of Cognizant Technology Solutions Corporation (NasdaqGS:CTSH) is 14.00000.
Earnings-per-share (EPS) ratio for CTSH is 3.23, exhibiting the allocation of the profit to each of its outstanding share of common stock. GD's profit will be $716.61 million for 20.88 P/E if the $2.40 EPS becomes a reality. At one point in the past year, the shares traded as low as $736.70 but has recovered 53.92% since then. BioScrip, Inc. (NASDAQ:BIOS) has declined 29.17% since December 6, 2016 and is downtrending. When investing in a volatile security, the risk of success is increased just as much as the risk of failure. Its up 0.28, from 0.98 in 2017Q1. Moreover, Weybosset Research & Management Llc has 5.9% invested in the company for 46,262 shares. Suntrust Banks Inc reported 0.02% stake. (NASDAQ:BIOS) for 1.03M shares. Retail Bank owns 6,680 shares. Continental Advsrs Lc has invested 0.13% in BioScrip, Inc. Fifth Third Bancorporation invested in 0.01% or 17,584 shares. (NASDAQ:BIOS) for 141,900 shares. Gsa Capital Llp reported 25,892 shares. Cognizant Technology Solutions makes up 1.7% of Pegasus Partners Ltd.'s portfolio, making the stock its 6th largest holding. Mitsubishi Ufj Secs Communication accumulated 180 shares. M&T Bancorporation owns 80,000 shares. 45,175 were reported by Captrust. Petrus Com Lta has 187,200 shares for 2.89% of their portfolio.
BioScrip, Inc. provides home infusion services in the United States. The firm's price-to-sales ratio was noted 2.87 in contrast with an overall industry average of 4.73. It is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
- Islanders get struck down by Lightning
- Hewlett (HPQ) Holding Upped by Meag Munich Ergo Kapitalanlagegesellschaft Mbh
- Analysts Recommendations American Express Company (AXP)
- Ryan Reynolds cast in live-action Pokemon movie Detective Pikachu
- Life is Strange: Before the Storm Episode Three Release Date Revealed
- Syria Gov't Delegation Stays Away From Geneva Peace Talks
- Lawsuit challenges Trump's financial bureau appointment
- Short Interest in BHP Billiton PLC (BBL) Drops By 38.5%
- Britain must apologise for colonial-era massacre
- Alternate juror supports murder acquittal in pier shooting
- US TV anchor confronts racist email from viewer live on air
- LG V30+ India launch pegged for December 13
- Stock'S Earning Overview Lam Research Corporation (LRCX)